Moreover, high expression of WTAP, ALKBH5, or IGF2BP1 predicts a poor prognosis in AML patients [70, 76, 77, 79], while the expression of METTL3, METTL14, FTO, and YTHDF2 is not correlated with prognosis. Here, IGF2BP1 is linked to acute myeloid leukemia.